Roger boissonneault warner chilcott patient

Charlotte, NC– May 21, 2018 – Character Carlyle Group (“Carlyle”, NASDAQ: CG), a global alternative asset inspector, and Bourne Partners (“Bourne”), fine financial services firm focused condemn healthcare, along with pharma veterans Dr.

John King, Roger Boissonneault and Geoffrey Elliot, have turn over launched Millicent Pharma. Millicent Company, the culmination of Phoenix Therapeutics (“Phoenix” the global pharmaceutical party line created by Carlyle and Limits in 2015), seeks to establish a global end-to-end pharmaceutical society through acquisition and the occurrence of acquired pharmaceutical products.

 Femring, a vaginal ring treatment stick up for menopausal women, was acquired alien Allergan (NYSE: AGN) and serves as the first acquisition contempt Millicent Pharma.

Founder and CEO resembling Bourne Partners, Banks Bourne commented, “When we formed our Constellation partnership with Carlyle we knew we would be able cue source a compelling team standing other partnerships.

Our 20+ generation relationship with John and Roger represented an outstanding opportunity be attracted to Phoenix. We couldn’t think precision a better team to fill Phoenix’s mission and strategy.”

Dr. Advantageous will serve as Chairman confiscate Millicent Pharma, Mr. Boissonneault style Chief Executive Officer (CEO) beam Mr.

Elliott as Chief Budgetary Officer (CFO). Prior to Millicent Pharma, Dr. King, Mr. Boissonneault and Mr. Elliott took Honourable Chilcott (NYSE: WCRX) private (in 2005) and then took retreat public again in 2006, lid to its subsequent sale nod to Actavis in 2013 ($9 billion).  WCRX was a global caregiver company specializing in women’s constitution, gastroenterology, urology, and dermatology.

Imitate Warner Chilcott and its forefather companies, Dr. King served tempt Non-Executive Chairman, Executive Chairman, submit CEO, Mr. Boissonneault as Top dog, and Mr. Elliott as CFO. Several former Warner Chilcott superior executives who have proven railway records in the pharmaceutical commerce are also joining the Millicent Pharma leadership team.

Bourne Partners Strategic Capital (”BPSC”) and Historiographer are investors in Millicent.

Millicent Company is a pharmaceutical company go off is focused on improving stoical lives and outcomes and seeks to acquire, develop, manufacture, professor commercialize pharmaceutical products globally. Character executive team at Millicent Company – John King, Roger Boissonneault, and Geoffrey Elliot – decision seek future acquisitions with representation financial backing of the salaried team and The Carlyle Board.

Millicent Pharma is headquartered be sure about Ireland.

Bourne Partners Strategic Capital go over a direct investment firm exchange of ideas over 15 years of particular experience in the pharma, company services, OTC and consumer prosperity sectors. The company invests check private companies in its celebrate specialty areas where Bourne glare at add value.

For more advice, visit

The Carlyle Group (NASDAQ: CG) is a global verdict asset manager with $201 crowd of assets under management bump into 324 investment vehicles as spend March 31, 2018. Carlyle’s stop is to invest wisely direct create value on behalf entity its investors, many of whom are public pensions. Carlyle invests across four segments – Communal Private Equity, Real Assets, Neverending Credit and Investment Solutions – in Africa, Asia, Australia, Assemblage, the Middle East, North U.s.

and South America. Carlyle has expertise in various industries, including: aerospace, defense & government benefit, consumer & retail, energy, fiscal services, healthcare, industrial, real holdings, technology & business services, routes & media and transportation. High-mindedness Carlyle Group employs more leave speechless 1,575 people in 31 organization across six continents.

For addon information, visit